“…15 The other is to establish vascular and naive cellular matrix (a potential back-bone structure as ECM, microvascular fragments [MCFs, containing fragments of arterioles, venules, and capillaries identified by cluster of differentiation 31 [CD31 or platelet endothelial cell adhesion molecule-1] and α-smooth muscle actin, vascular endothelial growth factor [GF], platelet-derived GF, hepatocyte GF, hepatocyte GF, transforming GF-β, basic fibroblast GF, insulin-like GF 1, and granulocyte-macrophage colony-stimulating factor] and possible various pockets of GFs, cytokines, adipokines, and transcriptional factors [lipoxin, resolvins, protectins, neurotrophic factors, angiogenin, matrix metalloproteinase 9, leukemia inhibitory factor, macrophage migration factor, bone marrow protein 2, 4, and interleukin 1RA, 4, 8, 10, 11, and 13] which altogether from secretomes). 12,15 The use of adipose tissue as a resource takes advantages, which not only can be obtained by easy and reproducible manner (accessibility, harvesting, potential, extraction by a non-terminal procedure) but also is absence of ethical concerns. 14,15 Additionally, besides nanofat, ASCs, and secretomes, the products of adipose tissue including macrofat, microfat, MCFs, the stromal vascular fraction (SVF), and exosomes, contributing to various needs for generative medicine, based on minimal or more manipulation procedure of the adipose tissue.…”